M ALister (London)
The Integrated Implant: A Plea for its Revival
The purpose of this paper is to revive an interest in the integrated orbital implant because I consider that. it gives a natural appearance to an artificial eye far superior to that obtained by any buried implant. Not only does it allow excellent movement of the prosthesis, but it gives a natural fullness to the upper lid which is absen:t in the case of even the best buried implants. Furthermore, even if the exposed implant has to be removed later, which happens sometimes, the subsequent cosmetic result is as good as that presented by most ordinary enucleations, even when a buried implant has been employed.
Integrated implants made their appearance in 1947, the most popular being that introduced by Cutler. It consisted of a white polythene cylinder with a flat front in which there was a square hole to receive a peg on the back of the prosthesis; a gold ring was attached by four short spokes to the cicumference of the cylinder. At operation the four recti were secured to the ring and their attachments well covered by Tenon's capsule and conjunctiva in such a manner as to leave the flat surface of the implant exposed.
The operation for insertion of this implant was time consuming and laborious so the implant was soon replaced by one made of tantalum (Hudson ). This proved a sad failure (Choyce 1952) and it rang the knell of all exposed implants. However, in 1960 I became aware that several of the original implants were still giving good service and decided to give it a further trial. A brief summary of my cases in which a gold ring implant has been employed and which have been traced is given in Table 1 .
In conclusion, I must emphasize that strict attention to the technique is essential for consistent results; details of the operation are given by Cutler (1947) . Although the operation is time consuming, the satisfactory appearance it offers fully justifies it. A possible alternative to it is the Arruga two-pin implant but I have had no experience of the latter.
[The cases were illustrated by slides and a representative group of patients was shown.] Mr Peter Choyce (Hospital for Tropical Diseases, London)
The Mark VI, Mark VII and Mark VIII Cbiyce Anterior Chamber Implants1
The reasons for continuing the search for an ever more satisfactory implant are as follows:
(1) The occurrence of occasional cases of endothelial corneal dystrophy, thought to be due to contact between portions of the implant and the endothelium, and therefore related to the residual depth of anterior chamber.
(2) Additional trauma has been observed to displace some of the earlier implants so as to increase the likelihood of corneal touch, and/or to traumatize the iris root or the ciliary body by the feet or the tip of the implant. This has resulted in one or two cases of recurrent hyphima associated with secondary glaucoma.
The Mark VI Implant This was identical to the mark V (Choyce 1964 ,  Fig 18) , with the important difference that instead of being evenly curved, the outer 2 mm of the feet and the tip of the implant were flattened, the object being to carry the implant farther away from the cornea both centrally and peripherally, as in the mark II model of Ridley's tripod anterior chamber implant (Choyce 1964 , Fig 19) , and also to lessen the tendency of the feet and tip to damage the iris root and ciliary body in the event of further trauma to the eye.
Fourteen mark VI implants were used, with no complications, and with satisfactory results. The post-operative anterior chamber depths averaged 2-3 mm with a range from 19 to 2-6 mm. This increase of 0-1 mm over the average depth obtained with a mark V implant seems to be the result of flattening the feet and the tip of the implant.
The Mark VII Implant The next step was to dispense with the 0O5 mm inferior ledge, so the mark VII implant is the same as the mark VI without this ledge. Two cases were treated in this way, again with a satisfactory outcome, and with anterior chamber depths of 2-3 and 2-5 mm respectively (average 2-4 mm).
The Mark VIIIImplant In this model a dovetail formation is provided at each end, so as to give 4-point and not 3-point fixation within -the anterior chamber. There is no inferior ledge, so there is no difference between implants for the right and left eyes. This simplifies the ordering of a set of implants and eliminates one source of manufacturing error. Each foot houses a 0 5 mm perforation, so there are four of these perforations instead of three as in the mark V, VI and VII models. A further modification has been to make this mark in two sizes -a standard size for the fairly large eye and a slightly reduced model for the smaller eye. For lengths of 12-5 mm and upwards the full-size model is used, for lengths of 12 mm and less the reduced size is used. So if the horizontal corneal diameter is noted on the order form as 11 5 mm the manufacturers will supply two implants 12 mm in length of the reduced dimensions, two of the 12 5 and two ofthe 13 mm length of the full dimensions. They will do this automatically without being reminded of the necessity for so doing by the surgeon who orders the implants.
The full-size mark VIII implant is shown in the upper part of Fig 1, and that with reduced dimensions in the lower part. It will be noted that the reduction takes place not in the optic, which is the same in both sizes, but in the haptic portions where the supero-inferior diameter at each extremity is reduced by 1 mm. The mark VIII implant is also available with coloured opaque portions if desired.
The purpose of introducing 4-point fixation is to increase the stability of the implant on a longterm basis. Since their use became routine eighteen months ago no movement of any implant in the anterior chamber has been observed, and if any of the eyes have been subjected to further trauma there has been no damage to the iris root or ciliary body up to this time in any cases.
The reason for producing the reduced-size version of the mark VIII implant is to have as small an implant as possible in the smaller eye, so that the anterior chamber is as deep as possible. This is effected by flattening the four feet of the implant; by abbreviating its supero-inferior measurements, the upper and lower borders of the implant are kept as far away from the cornea as possible.
From the standpoint of surgical technique the mark VIII implant is a little more difficult to insert than the mark V. Because it has no inferior ledge a shorter incision suffices, but the flattened feet are more difficult to retain in the angle temporally, and more care and additional sutures up to the number of 4 may be necessary adequately to close the incision. There is also, as one would expect, a greater tendency for the iris to bulge above and below the implant and between its feet nasally and temporally, and reformation of the anterior chamber by the injection of air or saline is obligatory before the operation may be regarded as satisfactorily completed. One or 2 patients have left the operating table still with some bulging of the iris, but fortyeight hours later, with proper reformation of the anterior chamber, this has all disappeared. The incidence of post-operative intra-ocular iris prolapse while using the mark VIII implant (Choyce 1964, p 90) Post-operative anterior chamber depths range from 2-5 to 3-2 mm with an average of 2-9 mm. The average depth for the 100 mark I cases was 1 68 mm and for the mark II with the thin haptic 1-94 mm. For the mark V implant with the very thin haptic, 2-2 mm was the average (Choyce 1964, p 192) and it is felt that this figure of 2-9 mm for the mark VIII implant is very satisfactory.
It is unfortunate that another three to four years' observation is called for before we can be sure that this increase in the post-operative anterior chamber depth reduces the incidence of endothelial corneal dystrophy, but it seems likely that it will. At present none of the 71 cases has developed this complication; the only incident to mar this series so far has been the necessity to remove an implant from a diabetic patient because of chronic iritis.
All 71 mark VIII implants have been inserted into aphakic eyes. For the phakic eye the flattening of the 4 feet should be limited to the outer 1 mm so as to avoid pressure by the feet on the crystalline lens through the iris.
Summary
(1) The Choyce mark VI, mark VII and mark VIII anterior chamber implants are described. They all adhere to the original Strampelli (1953) principle of a one-piece, all-Perspex, fixed-length implant, depending on internal angle fixation for their stability.
(2) The mark VIII implant, which differs in several important respects from the mark V implant, has taken its place as the implant recommended for general use.
